City of Hope
Founder and Foundational Partner | Duarte, California
If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.
If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.
Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. For over a decade, City of Hope has been identified as one of the nation’s elite cancer hospitals by U.S. News & World Report.
Visit cityofhope.org to learn more about City of Hope.
City of Hope is one of 53 National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers in the United States. Additionally, they have received the highest ranking possible for a U.S. cancer center — “exceptional” — by the NCI. They are recognized as the 8th “Best Hospital” for cancer in the nation by U.S. News & World Report.
Their reputation for groundbreaking discoveries, innovative treatments and compassionate care make City of Hope a leader in the fight to help patients here in the United States and around the world conquer cancer.
City of Hope is located in Southern California and extends our coverage to the Western and Southwestern Region of the United States.
As oncologic innovation continues to develop at an extraordinary pace, you can connect to our specialists with National Cancer Institute (NCI)–Designated Comprehensive Cancer Centers for no-cost support. If an individual is eligible for our employee benefit of cancer support services through their employer plan, our subspecialists can provide ever-evolving expertise on the latest advancements in their specific cancer.
03/21/23 - City of Hope
City of Hope’s Idoroenyi Amanam, M.D. is getting noticed for his abilities, including recognition from MPN Research Foundation, and National Institutes of Health. Amanam’s focuses on the relative obscurity of MPNs, a group of blood cancers called myeloproliferative neoplasms (MPN). MPNs are remarkably rare, as well as the expertise in the field. A typical oncologist might never see a case of MPN. Read more
02/02/23 -
Treatments for medical conditions like cancer and heart disease can leave lasting physical and mental scars. Research showed that 58% of people who underwent treatment for cancer had a negative body image as a result. As a cancer survivor herself, Dr. Bernhardt, a board-certified clinical health psychologist at Northwestern Medicine, shares advice on how to cope with body image issues after a major medical event. Read more
10/25/22 -
With rising rates of colorectal cancer in adults under 50, this research is a first step to noninvasively and inexpensively detect colorectal cancer at an earlier and more treatable stage. Read more
City of Hope is a world renowned cancer research and treatment center based in southern California. It is a National Cancer Institute-designated comprehensive cancer center, in addition to being a founding member of the National Comprehensive Cancer Network, making it a national leader in advancing research and treatment protocols. For over a decade, City of Hope has been identified as one of the nation’s elite cancer hospitals by U.S. News & World Report.
Dana-Farber Cancer Institute in Boston, MA is a Harvard Medical School teaching hospital. It is the #1 ranked cancer hospital in New England by US News & World Report. Nationwide, it is the only cancer hospital to be ranked in the top 5 for both adult and pediatric oncology care. Dana-Farber is dedicated to a unique balance of cancer care and research, translating discovery into new therapies for patients around the world and offering more than 1,100 clinical trials.
Dana-Farber is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), an NCI-designated Comprehensive Cancer Center, a founding member of the National Comprehensive Cancer Network, the top academic recipient of grant funding from the National Cancer Institute (NCI), and has the most highly cited research of any U.S. cancer center.
Emory Healthcare, with more than 24,000 employees and 11 hospitals, is the most comprehensive academic health system in Georgia. System-wide, it has 2,796 licensed patient beds, more than 2,800 physicians practicing in more than 70 specialties, serving metro Atlanta with 250 locations. It also provides services to greater Georgia through a joint venture at St. Francis–Emory Healthcare Hospital in Columbus, 10 regional affiliate hospitals, and its clinically integrated physician network.
As the National Cancer Institute (NCI)-designated comprehensive cancer center for the state of Georgia, Winship Cancer Institute of Emory University discovers, develops and delivers some of the world's most effective ways to prevent, detect, diagnose and treat each patient's unique cancer. Winship leverages the depth and breadth of Emory University and collaborates with other NCI-designated cancer centers and leading cancer organizations. Winship investigators conducted more than 300 therapeutic clinical trials and enrolled more than 900 patients in 2020. Winship has more than 500 faculty and received $80 million in cancer research funding in 2020, $33 million of that from the NCI.
Northwestern Medicine is a nationally recognized health system that provides world-class care. Anchored by Northwestern Memorial Hospital, ranked No. 1 in Illinois and No. 9 in the nation by US News and World Report. Northwestern Medicine encompasses more than 200 locations including 10 hospitals, the Northwestern University Feinberg School of Medicine and The Robert H. Lurie Comprehensive Cancer Center.
Backed by the Lurie Cancer Center, Northwestern Memorial Hospital is ranked #9 in the nation by US News and World Report and is part of a select group of National Cancer Institute (NCI) designated Comprehensive Cancer Centers. Dedicated to overcoming cancer through scientific discovery, the Lurie Cancer Center provides compassionate, leading edge cancer care in a state of the art facility.
Fred Hutchinson Cancer Center combines adult cancer care and advanced scientific research, and has a history of discoveries that treat, cure and identify prevention strategies for cancer and infectious diseases. The organization was renamed in April 2022, following the merger of long-time partners, Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance. Fred Hutchinson Cancer Center is an independent, nonprofit organization that serves as UW Medicine’s cancer program.
Fred Hutch has been a National Cancer Institute-designated cancer center since 1973. Global leadership in bone marrow transplantation, HIV/AIDS, immunotherapy and COVID-19 helped Fred Hutch earn recognition as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and has network affiliations with hospitals in five states.
As part of the Johns Hopkins Medicine academic health system and Johns Hopkins University School of Medicine, the Kimmel Cancer Center has five locations in the Baltimore and Greater Washington, D.C., regions. Designated by the National Cancer Institute as one of the first comprehensive cancer centers in the country, its physicians and scientists are recognized leaders throughout the nation and the world.
The Kimmel Cancer Center understands that each patient is unique and it provides a tailored approach to care by multidisciplinary teams of specialists. Its patients have access to a large number of clinical trials and supportive care resources for themselves and their caregivers. From immunotherapy and proton therapy, to molecular tumor board-guided treatments, its physicians, nurses, and pharmacists are dedicated to providing the best care possible backed by innovative research.
UT Southwestern Medical Center Partners with AccessHope to extend nationwide access to cancer expertise